Oncocyte is a leading biopharmaceutical company based in Nashville, TN, specializing in innovative and streamlined solutions for drug discovery in the era of precision medicine. With over a decade of experience in molecular and multivariate assay development, they offer a comprehensive suite of tissue-based and blood-based technologies to accelerate and de-risk biomarker-driven clinical trials.
Their services include a proprietary immuno-oncology platform, custom TMB panels, next-generation sequencing (NGS), RNA-seq, targeted PCR panels, and more, enabling them to identify and validate novel targets for clinically actionable diagnostics and therapeutics. With ISO and CLIA certifications, as well as CAP accreditation, Oncocyte's laboratory is qualified by top diagnostic and pharma companies for clinical trial testing, and they have supported numerous partners with FDA and other regulatory submissions.
Generated from the website